Results 291 to 300 of about 111,950 (304)

BRCA1 and BRCA2 mutations correlate with TP53 abnormalities and presence of immune cell infiltrates in ovarian high-grade serous carcinoma

Modern Pathology, 2012
Katy Milne, Jessica N McAlpine, Sohrab P. Shah   +2 more
exaly  

Role of direct interaction in BRCA1 inhibition of estrogen receptor activity

Oncogene, 2001
Michael R Erdos, Richard Pestell, Peter Kushner   +2 more
exaly  

BRCA1 dysfunction in sporadic basal-like breast cancer

Oncogene, 2006
Kay Savage, K Ryder, C E Gillett
exaly  

BRCA1 deficient embryonic stem cells display a decreased homologous recombination frequency and an increased frequency of non-homologous recombination that is corrected by expression of a Brca1 transgene

Oncogene, 2000
Beverly Koller, John N Snouwaert, Lauren Dibiase   +2 more
exaly  

An aCGH classifier derived from BRCA1-mutated breast cancer and benefit of high-dose platinum-based chemotherapy in HER2-negative breast cancer patients

Annals of Oncology, 2011
Sabine Linn, Michael Hauptmann, Marjanka K Schmidt   +2 more
exaly  

Genetic Heterogeneity and Penetrance Analysis of the BRCA1 and BRCA2 Genes in Breast Cancer Families

American Journal of Human Genetics, 1998
Susan L Neuhausen, Jeffery Struewing, T R Rebbeck   +2 more
exaly  

BRCA1 mRNA expression and outcome to neoadjuvant cisplatin-based chemotherapy in bladder cancer

Annals of Oncology, 2011
Albert Font, M Taron, A Gimenez-Capitan
exaly  

BRCA1 binds c-Myc and inhibits its transcriptional and transforming activity in cells

Oncogene, 1998
Hongtao Zhang, Qiang Wang, M I Greene
exaly  

BAP1: a novel ubiquitin hydrolase which binds to the BRCA1 RING finger and enhances BRCA1-mediated cell growth suppression

Oncogene, 1998
John Minna, Lewis A Chodosh, Niels Tommerup   +2 more
exaly  

BRCA1

openaire   +1 more source